Pfizer Ltd - PFIZER Share Price

Sector: Pharmaceuticals | ISIN: INE182A01018
₹ 4,473.05 (1.65%) icon18 May, 2024, 12:00:00 AM
Open
₹ 4,444.00
Prev. Close
₹ 4,400.55
Turnover(lac)
₹ 0.00
Day's High
₹ 4,548.95
Day's Low
₹ 4,440.00
52 Wk High
₹ 5,000.00
52 Wk Low
₹ 3,720.00
Book Value
₹ 821.60
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 20,463.19
P/E
40.29
EPS
111.03
Div. Yield
0.78

Pfizer Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/18/2024 12:00:00 AM

    ₹ 4473.05 72.50 1.65
  • Open
  • ₹ 4,444
  • Prev. Close
  • ₹ 4,400.55
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 4,548.95
  • Day's Low
  • ₹ 4,440
  • 52 Week's High
  • ₹ 5,000
  • 52 Week's Low
  • ₹ 3,720
  • Book Value
  • ₹ 821.6
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 20,463.19
  • P/E
  • 40.29
  • EPS
  • 111.03
  • Divi. Yield
  • 0.78

Pfizer Ltd Corporate Actions

06 May , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

22 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Oct , 2023

12:00 AM

27 Jul , 2023

12:00 AM

AGM

Announcement date: 27 Jul , 2023

View Details

04 Aug , 2023

12:00 AM

15 May , 2023

12:00 AM

Dividend

Dividend amount: 35
Announcement date: 15 May , 2023

View Details

15 May , 2023

12:00 AM

Dividend

Dividend amount: 5
Announcement date: 15 May , 2023

View Details

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Pfizer Ltd News and Update

Image not found

The property transfer is contingent upon receiving the necessary approvals from relevant regulatory authorities, including the MIDC

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Pfizer Ltd SHAREHOLDING SNAPSHOT
20 May , 2024 | 01:45 AM

PROMOTER - TOTAL63.92%

Indian: 0.00%

Foreign: 63.9224%

NON-PROMOTER - TOTAL 36.08%

Institutions: 18.66%

Non-Institutions: 17.42%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Pfizer Ltd FINANCIALS

View Profit & Loss Graph

Pfizer Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Pfizer Ltd

  • Prajeet Nair
  • Company Sec. & Compli. Officer
  • Uday Khanna
  • Independent Director
  • Sunil Lalbhai
  • Independent Director
  • MILIND ANIL PATIL
  • Executive Director (Finance)
  • MEENA GANESH
  • Independent Director
  • Samir Kazi
  • Executive Director
  • Pradip P Shah
  • Chairman & Independent Directo
  • Meenakshi Nevatia
  • Managing Director

Summary

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories. It has its own manufacturing facility at Goa and Thane. It has the distinction of being the first pharmaceutical company in India to start clinical research. The Company sells products in nearly 185 countries having 43 manufacturing sites globally. Their 6 primary therapeutic areas includes, Internal Medicine, Oncology, Hospital, Vaccines, Inflammation & Immunology and Rare Diseases.Pfizer Limited came to the Indian market in 21st November, 1950 through a company named Dumex Limited. The first production facility was set up at Darukhanna in Mumbai, where products like Protinex and Isonex (isoniazid - an anti -TB drug) were manufactured. Subsequently, this plant also produced Becosules and Corex. In 1960, Pfizer established a large and modern plant at Thane, near Mumbai, which housed manufacturing, quality control and product research facilities. This plant won a number of national safety awards. In November of the year 1965, the Company had entered into a licence agreement with Pfizer Corporation continuing the royalty-free licence granted to it for the use of Pfizer processes, technical know-how, etc., relating to the manufacture of existing products in the pharmaceutical, veterinary and agricultural fields and giving the Company the right to obtain from Pfizer... Read More


Reports by Pfizer Ltd


Reports by Pfizer Ltd

Company FAQ

No Record Found